Parallel Advisors’s KalVista Pharmaceuticals KALV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.1K | Buy |
1,423
+136
| +11% | +$1.54K | ﹤0.01% | 2263 |
|
|
2025
Q1 | $14.9K | Buy |
1,287
+1,184
| +1,150% | +$13.7K | ﹤0.01% | 2267 |
|
|
2024
Q4 | $872 | Buy |
103
+35
| +51% | +$296 | ﹤0.01% | 3112 |
|
|
2024
Q3 | $787 | Buy |
+68
| New | +$787 | ﹤0.01% | 3071 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 3448 |
|
|
2023
Q1 | – | Sell |
-382
| Closed | -$2.58K | – | 3460 |
|
|
2022
Q4 | $2.58K | Buy |
382
+363
| +1,911% | +$2.45K | ﹤0.01% | 2587 |
|
|
2022
Q3 | $0 | Buy |
+19
| New | – | ﹤0.01% | 3320 |
|
|
2021
Q4 | – | Sell |
-8
| Closed | – | – | 3188 |
|
|
2021
Q3 | $0 | Sell |
8
-37
| -82% | – | ﹤0.01% | 3139 |
|
|
2021
Q2 | $1K | Buy |
+45
| New | +$1K | ﹤0.01% | 2732 |
|